1. Risk factors for breast cancer from benign breast disease in a diverse population

   • Maria J. Worsham
   • Usha Raju
   • Sandra R. Wolman

   Preclinical Study 04 October 2008 Pages: 1 - 7

   

2. Intraductal approach to the detection of intraductal lesions of the breast

   • Tadaharu Matsunaga
   • Takeharu Misaka
   • Masahiko Fujii

   Preclinical Study 10 October 2008 Pages: 9 - 13

3. Biological significance of allele specific loss of the p53 gene in breast carcinomas

   • Pia P. Wegman
   • Nashwan J. Marcus
   • Sten Wingren

   Preclinical Study 14 October 2008 Pages: 15 - 20

   

4. Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab

   • Erin M. Goldblatt
   • Priscilla A. Erickson
   • Brittney-Shea Herbert

   Preclinical study 14 October 2008 Pages: 21 - 32

   

5. Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis

   • Zengshan Li
   • Latonya Carrier
   • Brian G. Rowan

   Preclinical Study 15 October 2008 Pages: 33 - 43

   

6. Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy

   • Katja Specht
   • Nadia Harbeck
   • Heinz Hoefler

   Preclinical study 17 October 2008 Pages: 45 - 56

   

7. The prognostic impact of occult nodal metastasis in early breast carcinoma

   • Daehoon Park
   • Rolf Kåresen
   • Torill Sauer

   Cinical Trial 15 February 2009 Pages: 57 - 66

   

8. Differentiation of benign and malignant breast lesions by mechanical imaging

   • Vladimir Egorov
   • Thomas Kearney
   • Armen Sarvazyan

   Clinical trial 21 March 2009 Pages: 67 - 80

   

9. Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study

   • Georgiana K. Ellis
   • Henry G. Bone
   • Dennis Kim

   Clinical Trial 24 March 2009 Pages: 81 - 87

   

10. Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

    • Hyo Song Kim
    • Yeon Hee Park
    • Young-Hyuck Im

    Clinical trial 26 March 2009 Pages: 89 - 97

    

11. Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention

    • Julia H. Rowland
    • Beth E. Meyerowitz
    • Patricia A. Ganz

    Clinical trial 24 April 2009 Pages: 99 - 111

    

12. MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells

    • Shawn P. Fessler
    • Mark T. Wotkowicz
    • Cynthia Bamdad

    Preclinical study 05 May 2009 Pages: 113 - 124

    

13. The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users

    • Monique J. Bijl
    • Ron H. N. van Schaik
    • Loes E. Visser

    Epidemiology 03 February 2009 Pages: 125 - 130

    

14. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers

    • Sharon Nofech-Mozes
    • Maureen Trudeau
    • Wedad M. Hanna

    Epidemiology 03 February 2009 Pages: 131 - 137

    

15. Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population

    • Hae Won Shin
    • Dong Young Noh
    • Young Ho Yun

    Epidemiology 04 February 2009 Pages: 139 - 150

    

16. A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer

    • Juan Manuel Rosa-Rosa
    • Guillermo Pita
    • Javier Benitez

    Epidemiology 10 February 2009 Pages: 151 - 159

    

17. Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

    • DeShawn Taylor
    • Celeste Leigh Pearce
    • Debra Hawes

    Epidemiology 10 February 2009 Pages: 161 - 168

    

18. A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women

    • Zhanwei Wang
    • Yan Xu
    • Hongbing Shen

    Epidemiology 10 February 2009 Pages: 169 - 175

19. Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists

    • Alice J. Sigurdson
    • Parveen Bhatti
    • Jeffery P. Struewing

    Epidemiology 12 February 2009 Pages: 177 - 184

20. Expression profile of microRNAs in c-Myc induced mouse mammary tumors

    • Yuan Sun
    • Jack Wu
    • D. Joshua Liao

    Brief Report 07 September 2008 Pages: 185 - 196

    

21. Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells

    • Hongjie Pan
    • Luke S. Wanami
    • Robin E. Bachelder

    Brief Report 12 September 2008 Pages: 197 - 205

    

22. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer

    • Natalia Bogdanova
    • Cezary Cybulski
    • Thilo Dörk

    Brief Report 21 September 2008 Pages: 207 - 211

    

23. Fish oil targets PTEN to regulate NFκB for downregulation of anti-apoptotic genes in breast tumor growth

    • Triparna Ghosh-Choudhury
    • Chandi C. Mandal
    • Nandini Ghosh-Choudhury

    Brief Report 26 October 2008 Pages: 213 - 228